TENAX THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Liabilities
TENAX THERAPEUTICS, INC. (TENX) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2024-03-28
- TENAX THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2023-12-31 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2023-03-31 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-12-31 was -$31.15K.
- TENAX THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2022-09-30 was -$30.54K.
- TENAX THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $0.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$119.39K.
- TENAX THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2021 was -$43.00K.
- TENAX THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2020 was -$60.38K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | -$31.15K derived: sum of 2 quarters · filed 2024-03-28 | -$61.69K derived: sum of 3 quarters · filed 2024-03-28 | -$90.83K derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | -$31.15K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$61.69K derived: sum of 2 quarters · filed 2024-03-28 | -$90.83K derived: sum of 3 quarters · filed 2024-03-28 | -$119.39K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$30.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$59.68K derived: sum of 2 quarters · filed 2023-11-13 | -$88.24K 10-Q · filed 2023-11-13 | -$113.35K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$29.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$57.71K 10-Q · filed 2023-08-14 | -$82.81K derived: sum of 3 quarters · filed 2023-08-14 | -$107.42K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$28.57K 10-Q · filed 2023-05-15 | -$53.67K derived: sum of 2 quarters · filed 2023-05-15 | -$78.28K derived: sum of 3 quarters · filed 2023-05-15 | -$71.56K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$25.11K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$49.72K derived: sum of 2 quarters · filed 2023-03-31 | -$43.00K derived: sum of 3 quarters · filed 2023-03-31 | -$43.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$24.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$17.89K derived: sum of 2 quarters · filed 2022-11-10 | -$17.89K 10-Q · filed 2022-11-10 | -$17.89K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $6.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $6.72K 10-Q · filed 2022-08-11 | $6.72K derived: sum of 3 quarters · filed 2022-08-11 | $6.72K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $0.00 derived: sum of 3 quarters · filed 2022-05-16 | -$30.74K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | -$30.74K derived: sum of 3 quarters · filed 2022-03-29 | -$60.38K 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$30.74K derived: sum of 2 quarters · filed 2021-11-15 | -$60.38K 10-Q · filed 2021-11-15 | -$86.25K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$30.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$60.38K 10-Q · filed 2021-08-16 | -$86.25K derived: sum of 3 quarters · filed 2021-08-16 | -$111.61K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | -$29.64K 10-Q · filed 2021-05-17 | -$55.51K derived: sum of 2 quarters · filed 2021-05-17 | -$80.87K derived: sum of 3 quarters · filed 2021-05-17 | -$105.73K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$25.87K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | -$51.23K derived: sum of 2 quarters · filed 2021-04-16 | -$76.09K derived: sum of 3 quarters · filed 2021-04-16 | -$99.98K 10-K/A · filed 2021-04-16 |
| 2019-09-30 | -$25.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$50.22K derived: sum of 2 quarters · filed 2020-11-16 | -$74.11K 10-Q · filed 2020-11-16 | -$74.11K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$24.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$48.75K 10-Q · filed 2020-08-14 | -$48.75K derived: sum of 3 quarters · filed 2020-08-14 | -$48.75K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | -$23.89K 10-Q · filed 2020-05-15 | -$23.89K derived: sum of 2 quarters · filed 2020-05-15 | -$23.89K derived: sum of 3 quarters · filed 2020-05-15 | -$23.89K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $0.00 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |